![David Liu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Liu
Företagsledare/Principal på
Harvard University
Förmögenhet: 62 M $ per 2026-09-30
Profil
David R.
Liu is the founder of Ensemble Therapeutics Corp., founded in 2004, Permeon Biologics, Inc., founded in 2008, Editas Medicine, Inc., founded in 2013, and Exo Therapeutics, Inc., founded in 2018.
Dr. Liu is also the founder of nChroma Bio, Inc.,Prime Medicine, Inc.,Pairwise Plants Services, Inc...
Dr. Liu is currently a Professor at Harvard University.
Dr. Liu is currently an Associate Member at Massachusetts Institute of Technology.
Dr. Liu completed undergraduate education at Harvard University.
Dr. Liu earned a doctorate from the University of California, Berkeley.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
PRIME MEDICINE, INC. 11,73 % | 2026-03-31 | 20 240 945 ( 11,73 % ) | 62 M $ | 2026-09-30 |
Aktiva positioner av David Liu
| Företag | Position | Start |
|---|---|---|
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Företagsledare/Principal | 2011-09-06 |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Företagsledare/Principal | 2011-09-06 |
Tidigare kända positioner av David Liu
| Företag | Position | Slut |
|---|---|---|
| PRIME MEDICINE, INC. | Grundare | - |
Exo Therapeutics, Inc.
 Exo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs and small-molecule enzyme inhibitor discovery platform that targets distal binding pockets of enzymes | Grundare | - |
Pairwise Plants Services
 Pairwise Plants Services Food: Major DiversifiedConsumer Non-Durables Engages in cultivation of crops | Grundare | - |
| EDITAS MEDICINE, INC. | Grundare | - |
David Lius utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
100
+
Första gradens relationer
9
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 9 |
|---|---|
Ensemble Therapeutics Corp.
 Ensemble Therapeutics Corp. Chemicals: Major DiversifiedProcess Industries Develops novel classes of therapeutics and bioassays for research and diagnostics | Process Industries |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Permeon Biologics, Inc.
 Permeon Biologics, Inc. BiotechnologyHealth Technology Develops intracellular biotherapeutics platform to enhance drug delivery | Health Technology |
Editas Medicine, Inc.
 Editas Medicine, Inc. BiotechnologyHealth Technology Manufactures gene editing medicines | Health Technology |
Pairwise Plants Services
Pairwise Plants Services Food: Major DiversifiedConsumer Non-Durables Engages in cultivation of crops | Consumer Non-Durables |
Exo Therapeutics, Inc.
Exo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs and small-molecule enzyme inhibitor discovery platform that targets distal binding pockets of enzymes | Health Technology |
Prime Medicine, Inc.
 Prime Medicine, Inc. BiotechnologyHealth Technology Develops CRISPR gene editing technology | Health Technology |
